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Abstract
The focal adhesion kinase (FAK) family kinases, including FAK
and proline-rich kinase 2 (Pyk)2, are the predominant mediators
of integrin αvβ3 signaling events that play an important role in
cell adhesion, osteoclast pathology, and angiogenesis, all
processes important in rheumatoid arthritis (RA). Using
immunohistochemical and western blot analysis, we studied the
distribution of phospho (p)FAK, pPyk2, pSrc, pPaxillin and
pPLCγ in the synovial tissue (ST) from patients with RA,
osteoarthritis (OA) and normal donors (NDs) as well as in RA ST
fibroblasts and peripheral blood differentiated macrophages
(PB MΦs) treated with tumor necrosis factor-α (TNFα) or
interleukin-1β (IL1β). RA and OA STs showed a greater
percentage of pFAK on lining cells and MΦs compared with ND
ST. RA ST fibroblasts expressed pFAK at baseline, which
increased with TNFα or IL1β stimulation. Pyk2 and Src were
phosphorylated more on RA versus OA and ND lining cells and
MΦs. pPyk2 was expressed on RA ST fibrobasts but not in MΦs
at baseline, however it was upregulated upon TNFα or IL1β
activation in both cell types. pSrc was expressed in RA ST
fibroblasts and MΦs at baseline and was further increased by
TNFα or IL1β stimulation. pPaxillin and pPLCγ were upregulated
in RA versus OA and ND lining cells and sublining MΦs.
Activation of the FAK family signaling cascade on RA and OA
lining cells may be responsible for cell adhesion and migration
into the diseased STs. Therapies targeting this novel signaling
pathway may be beneficial in RA.
Introduction
In rheumatoid arthritis (RA), macrophages (MΦs) derived from
circulating monocytes are key regulators of joint inflammation
and destruction. Hence, suppression of cell adhesion and
migration into the RA synovial tissue (ST) may ameliorate
inflammation. In this study we determined integrin-associated
signaling molecules that become activated, probably as a
result of inflammation in RA ST. Focal adhesion kinase (FAK)
and proline-rich tyrosine kinase (Pyk)2 are two members of a
family of nonreceptor protein tyrosine kinases that are acti-
vated by a variety of extracellular stimuli [1]. FAK and Pyk2
associate with the cytoskeleton and with integrin-signaling
complexes by binding to Src kinase and paxillin [2-5]. FAK is
rapidly tyrosine phosphorylated on cell adhesion, creating a
high-affinity binding site for Src and thereby increasing phos-
pholipase C (PLC)γ enzymatic activity [6]. Paxillin is a sub-
strate for the FAK-Src complex that functions as an adaptor
molecule for various signaling and structural proteins, and can
promote migration of fibroblasts, MΦs and endothelial cells [7-
11].
FAK expression is ubiquitous and FAK is activated by numer-
ous integrins, suggesting that FAK activation is common adhe-
sion-dependent signal [12-14]. Unlike FAK, Pyk2 expression is
highly cell-type and tissue specific. Pyk2 is tyrosine phospho-
rylated in response to stress (UV irradiation, tumor necrosis
factor-α (TNFα) and hyperosmotic shock), G protein-coupled
receptor agonists (angiotensin II, thrombin) and growth factors
(vascular endothelial growth factor (VEGF), basic fibroblast
growth factor (bFGF), and platelet derived growth factor
(PDGF) [15-17]. Although FAK activation is closely tied to
integrin-mediated adhesion, activation of Pyk2 can be inde-
pendent of cell adhesion [18]. FAK and Pyk2 are expressed in
osteoclasts, and both proteins are tyrosine phosphorylated in
response to integrin αvβ3 ligation, a process which may be
crucial for bone resorption [3,19]. Both FAK and Pyk2 play aPage 1 of 10
(page number not for citation purposes)
Arthritis Research & Therapy    Vol 9 No 5    Shahrara et al.central role in linking integrin αvβ3 signaling to the formation
of podosomes and actin rings in osteoclasts. Although FAK is
phosphorylated by Src, Pyk2 can be phosphorylated through
a Src- or a Ca2+-dependent pathway [18]. Additionally, FAK is
involved in angiopoietin-1 and VEGF-induced endothelial cell
migration and angiogenesis [8,20]; however, the role of Pyk2
in endothelial cell function has not been explored.
MΦs isolated from RA ST have the potential to differentiate to
osteoclasts in the presence of receptor activator of NF-kap-
paB ligand (RANKL) and macrophage colony stimulating fac-
tor (M-CSF) [21]. Stimulation of PB monocytes with M-CSF
mediates FAK activation, suggesting that FAK may be involved
in monocyte differentiation into MΦs [22]. Interestingly, in rat
adjuvant induced arthritis (AIA) intra-articular injection of dom-
inant negative FAK adenovirus reduces mononuclear cell
recruitment into the joint. Inhibition of FAK suppresses VEGF-
induced mononuclear cell migration into the AIA ankle [8]. This
suggests that suppression of FAK activation may be important
for reducing cell recruitment into RA ST.
In this study we investigated the expression pattern of pFAK,
pPyk2, pSrc, pPaxillin and pPLCγ in RA and OA ST. Activation
of these signaling proteins on RA and OA ST lining cells may
be responsible for monocyte adhesion and migration into the
diseased STs, whereas activation of these signaling proteins
on MΦs may be important for both monocyte to MΦ differenti-
ation as well as MΦ differentiation into osteoclasts.
Materials and methods
STs were obtained from patients diagnosed with RA and OA
undergoing arthroplasty or synovectomy. RA or OA were diag-
nosed according to the criteria of the American Collage of
Rheumatology [23,24]. Normal STs, were obtained from fresh
autopsies or amputations. STs, were snap frozen in OCT com-
pound (Miles, Elkhart, Indiana, USA). All samples were
obtained with Institutional Review Board approval additionally
informed patient consent or consent from next of kin was
documented.
Antibodies and immunohistochemistry
STs were cut into 4 μm sections and fixed in cold acetone for
20 minutes. Endogenous peroxidase was quenched by treat-
ment with 3% H2O2 for 5 minutes. STs were next pretreated
with 3% goat sera for 1 hour at 37°C before application of pri-
mary antibody in 4°C overnight. Indirect immunoperoxidase
staining was performed at 37°C for 1 hour. Polyclonal anti-
body (pAb) rabbit anti-human pFAK, pAb rabbit anti-human
pPyk2, pAb rabbit anti-human pSrc, pAb rabbit anti-human
pPaxillin and pAb rabbit anti-human pPLCγ were all purchased
from Biosource (Camarillo, California, USA) or Cell Signaling
Technology (Beverly, Massachusetts, USA), and were used at
a concentration of 1 μg/ml. Isotype-specific IgG (rabbit) was
used as a negative control. Staining was performed using Vec-
tor Elite ABC Kits (Vector, Burlingame, California, USA) and
diaminobenzidine (Kirkegaard and Perry, Gaithersburg, Mary-
land, USA) as a chromogen.
Microscopic analysis
Vascularity was defined as a score as follows: 1, marked
decrease in vessels; 2, normal density of vessels; 3, increased
density of vessels; 4, marked increase in vessel density,
resembling granulation tissue. Inflammation was defined as a
score as follows: 1, normal; 2, mildly increased number of
inflammatory cells, arrayed as individual cells; 3, moderately
increased number of inflammatory cells including distinct clus-
ters (aggregates); 4, marked diffuse infiltrate of inflammatory
cells. MΦs were distinguished from fibroblasts based on mor-
phology and CD 11b/c immunoreactivity. Score data were
pooled and the mean ± SEM was calculated in each data
group [25-27]. Each of the ST components was graded for
immunostaining by a frequency of attaining scale, scored 0–
100% where 0% indicates no staining and 100% indicates
that all cells were immunoreactive. The number of cells of a
given type that reacted with a specific antibody divided by the
total number of cells of that given type was defined as the per-
centage of reactivity. The mean percentage of reactivity was
determined for 3 high power fields (HPF) in STs for each cell
type and antibody analyzed. Each slide was evaluated by a sin-
gle blinded pathologist (GKH). Selected sections were ana-
lyzed by an additional observer (SS).
Cell culture and western blot analysis
RA fibroblasts were isolated from fresh STs by mincing and
digesting in a solution of dispase, collagenase and DNase
[28]. Cells were used at passage 4 or older, at which time they
are a homogeneous population of fibroblasts. Cells were cul-
tured in DMEM containing 10% heat-inactivated fetal bovine
serum (FBS) [29]. Mononuclear cells were isolated by Histo-
paque (Sigma Chemical Co., St. Louis, Missouri, USA) gradi-
ent centrifugation. PB monocytes were then isolated from the
mononuclear cells by Percoll (Sigma Chemical Co.) gradient
centrifugation and countercurrent centrifugal elutriation (Beck-
man-Coulter, Fullerton, California, USA) [29]. Following adher-
ence, monocytes were differentiated in vitro for 7 days in RPMI
containing 20% FBS plus 1 μg/ml polymyxin B sulfate (Sigma
Chemical Co). As PB monocytes were isolated from buffy
coats by elutriation polymyxin B was added to the media pre-
ventatively. The endotoxin levels in RPMI, FBS and PBS as
measured by Limulus Amebocyte Lysate (LAL) (QCL-1000;
Cambrex Bioscience, Maryland, USA) were below the lowest
detectable level of 0.1 endotoxin unit (EU). The endotoxin lev-
els in TNFα and IL1β were lower than 1.0 EU per 1 μg of the
cytokine as determined by the LAL method.
RA ST fibroblasts (cultured in DMEM with 10% FBS) and
MΦs (cultured in RPMI with 20% FBS) were either untreated
or treated with TNFα (10 ng/ml; R&D Systems, Minneapolis,
New Mexico, USA) [30] or IL1β (10 ng/ml; R&D Systems) [31]
for 0 to 120 min.Page 2 of 10
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[29]. Briefly, 60 μg of each sample was loaded on a 10%
SDS-PAGE gel and transferred to nitrocellulose membranes
using a semi-dry transblotting apparatus (Bio-Rad, Hercules,
California, USA). Nitrocellulose membranes were blocked with
5% nonfat milk in Tris-buffered saline Tween (TBST) buffer-20
mM Tris, 137 mM NaCl, pH 7.6, with 0.1% Tween for 60 min
at room temperature. Blots were probed with rabbit anti-pFAK
(Tyr 576/577), anti-pPyk2 (Tyr 402), or anti-pSrc (Tyr 527)
(Cell Signaling Technology) overnight and after stripping rep-
robed with rabbit anti-FAK, anti-Pyk2 or anti-Src (Cell Signal-
ing Technology at 1:1000) overnight.
Statistical analysis
The data was analyzed using Student's t-tests. P values less
than 0.05 were considered significant.
Results
pFAK localization
As expected, the inflammatory and vascularity scores were
higher in RA ST in comparison to OA and NDs. pFAK, was
expressed on ST lining cells in RA patients (mean of 15% pos-
itive cells) and OA (21%) more than on ND ST lining (1%) (P
=< 0.05) (Figure 1). pFAK staining on MΦs was also signifi-
cantly higher in RA (39%) and OA (25%) compared to ND
(4%) (P < 0.05). A few RA patients had positive immunostain-
ing for pFAK on ST endothelial cells and lymphocytes. Unstim-
ulated RA ST fibroblasts expressed pFAK; however, the
expression increased with TNFα stimulation at 45 min and
stayed upregulated until 120 min (Figure 1e). Similarly, IL1β
increased pFAK expression at 30, 45 and 120 min in RA ST
fibroblasts (Figure 1f). pFAK was not detected in MΦs with or
without TNFα or IL1β stimulation.
pPyk2 expression pattern
pPyk2 is one of the members of the nonreceptor protein tyro-
sine kinase FAK family and shares approximately 45%
sequence homology with FAK. Both proteins are important for
integrin-mediated adhesion and osteoclastogenesis [18].
pPyk2 immunostaining on ST lining and MΦs was significantly
higher in RA (lining cells = 60% and MΦs = 46%) compared
to OA (lining cells = 30% and MΦs = 23%) and ND (lining
cells= 17% and MΦs = 10%) (P < 0.05) (Figure 2). However,
no difference was detected in pPyk2 lining cells and MΦ
Figure 1
pFAK expression pattern in RA, OA and ND STnormal donor (ND) ST. (a) Rheumatoid arthritis synovial tissue (RA ST) stained with anti-pFAK, showing 
positive staining of the lining cell layer (black arrow) and subsynovial MΦs (white arrowhead) (×200). (b) Positive staining in osteoarthritis (OA) ST 
(×200). (c) Low pFAK reactivity in normal ST lining (arrow) and subsynovial macrophages (arrowhead). (d) The quantification of data obtained from 
a, b and c. Bars represent the mean and SEM. Inflam, inflammatory score; Vasc, vascularity score; Lining, ST lining cell layer; Mac, subsynovial MΦs. 
*P < 0.05. n, numbers of patients. RA ST fibroblasts were stimulated with (e) tumor necrosis factor-α (TNF-α) (10 ng/ml) or (f) interleukin-1β(IL-1β) 
(10 ng/ml) from 0–120 min. Cell lysates were examined by western blot analysis for pFAK or FAK expression. The results are representative of three 
experiments.Page 3 of 10
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pFAK and pPyk2 expression was similar in RA patient MΦs
(pFAK = 39%, pPyk2 = 46%); however, pPyk2 was highly
expressed on synovial lining (pFAK = 15%, pPyk2 = 60%)
compared to pFAK. The relative pattern of pFAK and pPyk2
expression was similar in OA patients' synovial lining (pFAK =
21%, pPyk2 = 30%) and MΦs (pFAK = 25%, pPyk2 = 23%).
Interestingly, although pFAK was similarly expressed in RA
and OA patients, the percentage of pPyk2 positive cells was
significantly higher in RA ST lining and sublining compared to
that of OA and ND. Rarely, RA patients showed positive immu-
nostaining for pPyk2 on ST endothelial cells, fibroblasts and
lymphocytes. pPyk2 was detected on unstimulated ST fibrob-
lasts, and the expression was further increased by TNFα and
IL1β stimulation and stayed upregulated up to 120 min (Figure
2d,e). MΦs did not express pPyk2 at baseline; however, after
30 to 45 min stimulation with TNFα or IL1β a robust level of
pPyk2 was detected. In MΦs, pPyk2 remained activated for 90
min subsequent to TNFα or IL1β activation and thereafter
markedly decreased (Figure 2f, h).
pSrc localization
Integrin αvβ3 activation induces FAK and Pyk2 phosphoryla-
tion via Src. Phosphorylation of FAK and Pyk2 results in forma-
tion of a signaling complex consisting of signaling molecules
including Src and paxillin. Formation of a Pyk2-Src complex
and the kinase activity of Src is required for bone resorption by
osteoclasts [32]. Src is highly phosphorylated in RA ST lining
cells (RA = 68%) and MΦs (RA = 57%) compared to OA (lin-
ing cells = 13%, MΦs = 16%) and ND ST (lining cells = 6%,
MΦs = 10%) (Figure 3). Although pSrc associated with both
FAK and Pyk2 signaling complexes, the expression pattern of
pSrc in RA ST lining (pSrc = 68%, pPyk2 = 60%) and sublin-
ing (pSrc = 57%, pPyk2 = 46%) was similar to pPyk2, while
pSrc immunostaining in OA ST lining (pSrc = 12%, pPyk2 =
30%, pFAK = 21%) and sublining (pSrc = 15%, pPyk2 =
23%, pFAK = 25%) was comparable to both Pyk2 and FAK.
RA ST endothelial cells and lymphocytes were occasionally
immunopositive for pSrc. Both RA ST fibroblasts and differen-
tiated MΦs expressed pSrc at baseline. pSrc remained
activated in RA ST fibroblasts stimulated with TNFα up to 120
Figure 2
Rheumatoid arthritis synovial tissue (RA ST) had higher pPyk2 immunopositive cells compared to osteoarthritis (OA) ST. (a) RA (×200), compared 
to (b) OA (×200) and (c) normal donor (ND) (×200). (d) is the quantification data obtained from figure a and b. Bars represent mean and SEM.  RA 
ST fibroblasts (e and f) or peripheral blood differentiated MΦs (g and h) were stimulated with TNF-α (10 ng/ml) or IL1-β (10 ng/ml) from 0–120 
min. Cell lysates were examined by western blot analysis for pPyk2 or Pyk2 expression. The results are representative of three experiments. Inflam, 
inflammatory score; Vasc, vascularity score; Lining, ST lining cell layer; Mac, subsynovial MΦs.Page 4 of 10
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longer than 45 min in RA ST fibroblasts (Figure 3e). In MΦs,
both TNFα and IL1β mediated robust activation of pSrc in a
time dependent manner up to 120 min (Figure 3f and 3h).
pPaxillin immunostaining
Paxillin is a multidomain adaptor protein that interacts with sig-
naling proteins such as FAK, Pyk2, Src and PLCγ [6,33]. The
phosphorylation of paxillin is modulated by cell adhesion. Pax-
illin is recruited to the FAK and Pyk2 signaling complex upon
integrin αvβ3 ligation in osteoclasts. We found that pPaxillin is
expressed on ST lining cells in RA patients (77%) to a signifi-
cantly higher degree than OA (37%) and ND (12%) (P <
0.05). pPaxillin immunostaining on MΦs was also significantly
higher in RA (70%) compared to OA (40%) and ND (14%) (P
< 0.05) (Figure 4). Similar to pSrc and pPyk2, paxillin was
highly phosphorylated in RA ST lining (pPaxillin = 77%, pSrc
= 68%, pPyk2 = 60%) and sublining (pPaxillin = 70%, pSrc =
57%, pPyk2 = 46%). In contrast, pPaxillin immunostaining on
OA lining (pPaxillin = 37%, pPyk2 = 30%, pFAK = 21%) and
sublining (pPaxillin = 40%, pPyk2 = 23%, pFAK = 25%) was
comparable to pFAK and pPyk2. Our findings suggest that the
colocalization and activation of FAK, Pyk2, Src and paxillin in
RA and OA patient's ST lining and sublining may be important
for integrin-mediated signaling.
pPLCγ expression pattern
Upon αvβ3 integrin-mediated adhesion, PLCγ associates with
the Pyk2 and FAK signaling complex [6,33]. M-CSF can also
induce association of αvβ3 integrins with PLCγ, PI3K and
Pyk2 in a Src-independent manner [33]. The inflammatory and
vascularity scores for pPLCγ immunostaining were higher in
RA ST in comparison to OA and ND. RA patients most
strongly expressed pPLCγ in the lining (67%) and on MΦs
(61%) in ST, compared to OA patients (lining = 9%, MΦs =
28%) and ND subjects (lining = 10%, MΦs = 14%)(Figure 5).
Interestingly pPLCγ immunostaining was similar on OA and
ND MΦs. The positive immunostaining of pPLCγ was compa-
rable to pPyk2 expression on RA ST lining (pPLCγ = 67%,
pPyk2 = 60%) and sublining (pPLCγ = 61%, pPyk2 = 46%).
Whereas, pPLCγ immunostaining on OA lining (pPLCγ = 9%,
pPyk2 = 30%) was lower than that of pPyk2. These results
suggest that Pyk2 and its associated signaling protein com-
plex, namely Src, paxillin, and PLCγ are activated on the RA ST
Figure 3
pSrc is upregulated in rheumatoid arthritis synovial tissue (RA ST) compared to osteoarthritis (OA) STi i . (a) RA (×200), compared to (b) OA (×200) 
and (c) normal donor (ND) (×200). (d) is the quantification data obtained from a and b. Bars represent mean and SEM. RA ST fibroblasts (e and f) 
or peripheral blood differentiated MΦs (g and h) were stimulated with TNF-α (10 ng/ml) or IL-1β (10 ng/ml) from 0–120 min. Cell lysates were 
examined by western blot analysis for pSrc or Src expression. The results are representative of three experiments. Inflam, inflammatory score; Vasc, 
vascularity score; Lining, ST lining cell layer; Mac, subsynovial MΦs.Page 5 of 10
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patients had positive immunostaining for pPLCγ on fibroblasts
and lymphocytes.
Discussion
RA is a chronic inflammatory disease characterized by synovial
hyperplasia. Proliferation of synovial cells leads to pannus for-
mation resulting in progressive bone and joint destruction. It
has been reported that FAK and Pyk2 are involved in integrin
αvβ3-mediated bone resorption [19,34-36]. Interestingly little
is known about the activation of these proteins in RA ST. In this
study we demonstrated the phosophorylation of FAK and Pyk2
as well as their downstream signaling molecules, namely, Src,
paxillin and PLCγ in arthritic ST (Figure 6). In addition, we
determined differences between diseased and ND STs in
regards to these molecules.
Angiogenesis is important in the growth and proliferation of
the RA ST pannus. FAK exerts its pro-angiogenic effects
through multiple mechanisms. Angiopoietin-1 induced
endothelial cell sprouting through FAK [37]. VEGF-mediated
endothelial cell migration and tube formation occurred through
FAK phosphorylation and subsequent PI3K activation [7].
Additionally, VEGF induced FAK tyrosine phosphorylation in
RAW cells.
VEGF-mediated RAW cell chemotaxis was suppressed by
dominant-negative FAK adenovirus [8]. In rat AIA, intra-articu-
lar injection of dominant negative adenoviral FAK reduced
mononuclear cell recruitment into the joint [8]. Inhibition of
FAK phosphorylation suppressed 3T3 fibroblast and human
umbilical vein endothelial cell migration [9]. These results sug-
gest that activation of the FAK signaling pathway may be
important for fibroblast, macrophage and endothelial cell
migration, all processes involved in RA ST inflammation and
proliferation.
Upon localization to the integrin cluster, FAK becomes auto-
phosphorylated and activates a number of downstream tar-
gets such as Src and PI3K. Src recruitment results in
phosphorylation of several other residues associated with
FAK, including paxillin [38]. Overexpression of FAK and PLCγ
in COS-7 cells increases PLCγ enzymatic activity and tyrosine
phosphorylation. FAK-induced PLCγ phosphorylation may be
due to FAK interaction and activation of Src family kinases [6].
Our results demonstrate that unlike Src, paxillin and PLCγ,
which are highly phosphorylated in RA ST lining, only low num-
bers of RA ST lining cells are immunopositive for pFAK. pFAK
staining in RA ST sublining was not greater than that in OA ST.
Nevertheless, pFAK staining in RA ST lining and sublining was
significantly higher than in ND STs. We additionally showed
Figure 4
Immunostaining of pPaxillin is increased in rheumatoid arthritis synovial tissue (RA ST) compared to osteoarthritis (OA) and normal donor (ND) ST. 
(a) demonstrates RA ST stained with anti-pPaxillin (×200), (b) shows positive staining in OA ST (×200). (c) Low pPaxillin reactivity in normal ST lin-
ing and subsynovial MΦs. (d) Is the quantification data obtained from a, b and c. Bars represent mean and SEM. Inflam, inflammatory score; Vasc, 
vascularity score; Lining, ST lining cell layer; Mac, subsynovial MΦs.Page 6 of 10
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RA ST fibroblasts. The pro-inflammatory cytokines TNFα and
IL1β further activated pFAK, pPyk2 and pSrc expression up to
120 min. The activation of the FAK-Src-paxillin-PLCγ pathway
in RA ST lining and sublining suggests that these signaling
proteins may be important for cell adhesion, cell migration and
perhaps even MΦ differentiation to osteoclasts.
MΦs isolated from Pyk2-null mice showed impaired migration
in response to chemokine stimulation. Ca2+ release in
response to chemokine stimulation as well as integrin-medi-
ated activation of PI3K were compromised in Pyk2-/- MΦs
[39]. These findings suggest that Pyk2 plays an important role
in MΦ function modulating migration [39]. Integrin αvβ3-medi-
ated signaling is dependent on the phosphorylation of Pyk2,
Src, paxillin and PLCγ. However, M-CSF can induce osteo-
clast differentiation by recruiting Pyk2, PLCγ and PI3K in a
Src-independent manner, an effect which is blocked by PLC
inhibitors [33]. These finding suggest that in the absence of
one Pyk2 family member, other signaling proteins can rescue
osteoclast function. Previous findings indicate that similar to
FAK, Pyk2 is essential for integrin-mediated adhesion, mono-
cyte-MΦ migration, and osteoclast signaling and differentia-
tion [18]. Our data demonstates that pPyk2, pSrc, pPaxillin
and pPLCγ are similarly expressed on RA ST lining and sublin-
ing, and this expression is significantly higher than that found
in OA and ND ST. The RA ST lining layer consists of fibrob-
lasts and MΦs that are in close proximity to one another.
Although, pPyk2 is undetected on MΦs or expressed in low
levels on RA ST fibroblasts, the presence of TNFα and IL1β
retains pPyk2 activation both in MΦs and RA ST fibroblasts.
In RA ST fibroblasts, baseline levels of pSrc are greater than
that of pFAK and pPyk2. Furthermore, TNFα and IL1β treat-
ment increased pSrc expression modestly in RA ST fibrob-
lasts. However, both cytokines induced pSrc levels to a
greater extent in MΦs. Src, paxillin and PLCγ are associated
with both integrin activation of FAK and Pyk2 pathways. It is
controversial whether Src kinase activity is essential for Pyk2-
induced osteoclast bone resorption as Pyk2 can be phospho-
rylated in a Ca2+-dependent manner [40]. In contrast, activa-
tion of Src is necessary for FAK function.
Circulating leukocytes, including lymphocytes and MΦs,
express high levels of paxillin [41]. Paxillin is a multi-domain
adapter molecule which is important for recruiting multiple sig-
naling protein to a specific location within the cell [42]. Paxillin
is modulated in response to integrin-mediated cell adhesion
and growth factors. In this study we demonstrate that pPaxillin
is detected twofold higher in RA ST lining and sublining com-
Figure 5
pPLCγ immunostaining is higher in rheumatoid arthritis synovial tissue (RA ST) in comparison to osteoarthritis (OA) and normal donor (ND) ST. (a) 
RA (×200), compared to (b) OA (×200) and (c) ND (×200). (d) The quantification data obtained from a, b and c. Bars represent mean and SEM. 
Inflam, inflammatory score; Vasc, vascularity score; Lining, ST lining cell layer; Mac, subsynovial MΦs.Page 7 of 10
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cells are significantly lower in ND ST lining and sublining com-
pared to RA ST, suggesting that activation of paxillin is asso-
ciated with RA inflammation.
PLCγ-null fibroblasts are defective in adhesion, spreading and
migration [43]. Integrin engagement by fibronectin induces
tyrosine phosphorylation of PLCγ1 and that this signaling
event requires Src activity [43]. Further, paxillin associates
with PLCγ1 in cells grown on fibronectin that may be mediated
by FAK or Pyk2 [44]. Although pPLCγ is significantly upregu-
lated on RA ST lining and sublining, it is similarly expressed in
OA and ND ST.
Multiple signal-transduction pathways have been implicated in
RA, most notably protein kinases such as MAPK [45] and
PI3K [46]. Preclinical models have confirmed the therapeutic
potential of p38 MAPK [47,48] and PI3K [49] inhibition and
clinical trials are under way to evaluate inhibitors for these sig-
naling pathways [45]. Although the preliminary results
obtained from animal models are promising, proof of safety has
not yet been obtained. As both p38 MAPK and PI3K are
involved in normal processes, inhibition of these signaling
pathways may produce untoward effects. Hence, identifying
the intermediary signaling proteins that are dysfunctional in RA
and not in ND may offer new therapeutic options.
Conclusion
Taken together, our results demonstrate that FAK family
kinases, including FAK and Pyk2, and their associated
signaling intermediates, namely Src, paxillin and PLCγ are
phosphorylated in RA ST lining and sublining. Although both
FAK and Pyk2 have been implicated in cell adhesion, migration
and osteoclast differentiation, alternative pathways may be
used for each function. Inhibiting activation of the FAK super-
family may suppress cell adhesion and migration into RA ST
and provide a novel therapeutic target.
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Figure 6
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